Production (Stage)
LeMaitre Vascular, Inc.
LMAT
$81.40
$2.282.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 59.87M | 55.72M | 54.82M | 55.85M | 53.48M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 59.87M | 55.72M | 54.82M | 55.85M | 53.48M |
| Cost of Revenue | 18.45M | 17.13M | 17.64M | 17.38M | 16.81M |
| Gross Profit | 41.42M | 38.59M | 37.18M | 38.47M | 36.67M |
| SG&A Expenses | 24.70M | 22.12M | 20.37M | 19.80M | 20.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.25M | 42.86M | 41.67M | 41.47M | 41.60M |
| Operating Income | 12.63M | 12.85M | 13.15M | 14.38M | 11.87M |
| Income Before Tax | 14.24M | 14.02M | 14.55M | 15.51M | 12.80M |
| Income Tax Expenses | 3.23M | 2.84M | 3.41M | 3.68M | 2.91M |
| Earnings from Continuing Operations | 11.01M | 11.18M | 11.14M | 11.83M | 9.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.01M | 11.18M | 11.14M | 11.83M | 9.89M |
| EBIT | 12.63M | 12.85M | 13.15M | 14.38M | 11.87M |
| EBITDA | 15.18M | 15.33M | 15.57M | 16.76M | 14.26M |
| EPS Basic | 0.49 | 0.50 | 0.50 | 0.53 | 0.44 |
| Normalized Basic EPS | 0.39 | 0.39 | 0.40 | 0.43 | 0.36 |
| EPS Diluted | 0.48 | 0.48 | 0.49 | 0.52 | 0.44 |
| Normalized Diluted EPS | 0.39 | 0.38 | 0.40 | 0.43 | 0.35 |
| Average Basic Shares Outstanding | 22.57M | 22.51M | 22.48M | 22.46M | 22.37M |
| Average Diluted Shares Outstanding | 22.90M | 22.90M | 22.84M | 22.73M | 22.57M |
| Dividend Per Share | 0.20 | 0.16 | 0.16 | 0.16 | 0.16 |
| Payout Ratio | 41.02% | 32.19% | 32.28% | 30.38% | 36.30% |